| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $114K | — | -98.5% |
| SG&A Expense | $5.4M | — | +63.9% |
| Operating Income | -$27.7M | — | -153.5% |
| Income Tax | $0 | — | — |
| Net Income | -$27.7M | — | -155.0% |
| EPS (Basic) | -$2.53 | — | +19.9% |
| EPS (Diluted) | -$2.53 | — | +19.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.8M | -76.6% | -91.6% |
| Current Assets | $2.4M | -70.4% | -89.1% |
| Total Assets | $10.7M | -36.5% | -66.6% |
| Current Liabilities | $3.3M | -0.1% | -74.9% |
| Total Liabilities | $9.9M | -3.3% | -52.8% |
| Stockholders' Equity | $822K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.6M | — | +5.5% |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $1.7M | — | +335.2% |
| Free Cash Flow | -$7.6M | — | +5.5% |
| -92.6% |